493 related articles for article (PubMed ID: 22016070)
1. Direct mutation analysis by high-throughput sequencing: from germline to low-abundant, somatic variants.
Gundry M; Vijg J
Mutat Res; 2012 Jan; 729(1-2):1-15. PubMed ID: 22016070
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutations, genome mosaicism, cancer and aging.
Vijg J
Curr Opin Genet Dev; 2014 Jun; 26():141-9. PubMed ID: 25282114
[TBL] [Abstract][Full Text] [Related]
3. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
4. Evaluating somatic tumor mutation detection without matched normal samples.
Teer JK; Zhang Y; Chen L; Welsh EA; Cress WD; Eschrich SA; Berglund AE
Hum Genomics; 2017 Sep; 11(1):22. PubMed ID: 28870239
[TBL] [Abstract][Full Text] [Related]
5. Somatic Mutagenesis in Mammals and Its Implications for Human Disease and Aging.
Zhang L; Vijg J
Annu Rev Genet; 2018 Nov; 52():397-419. PubMed ID: 30212236
[TBL] [Abstract][Full Text] [Related]
6. Detecting statistical interaction between somatic mutational events and germline variation from next-generation sequence data.
Hu H; Huff CD
Pac Symp Biocomput; 2014; ():51-62. PubMed ID: 24297533
[TBL] [Abstract][Full Text] [Related]
7. The Rise and Rise of Exome Sequencing.
Ku CS; Cooper DN; Patrinos GP
Public Health Genomics; 2016; 19(6):315-324. PubMed ID: 27898412
[TBL] [Abstract][Full Text] [Related]
8. Identification of somatic mutations in postmortem human brains by whole genome sequencing and their implications for psychiatric disorders.
Nishioka M; Bundo M; Ueda J; Katsuoka F; Sato Y; Kuroki Y; Ishii T; Ukai W; Murayama S; Hashimoto E; Nagasaki M; Yasuda J; Kasai K; Kato T; Iwamoto K
Psychiatry Clin Neurosci; 2018 Apr; 72(4):280-294. PubMed ID: 29283202
[TBL] [Abstract][Full Text] [Related]
9. Pan-cancer analysis of whole genomes.
ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic cancer genome sequencing and the contribution of germline variants.
Kilpivaara O; Aaltonen LA
Science; 2013 Mar; 339(6127):1559-62. PubMed ID: 23539595
[TBL] [Abstract][Full Text] [Related]
11. Whole genome sequencing for quantifying germline mutation frequency in humans and model species: cautious optimism.
Beal MA; Glenn TC; Somers CM
Mutat Res; 2012; 750(2):96-106. PubMed ID: 22178956
[TBL] [Abstract][Full Text] [Related]
12. ISOWN: accurate somatic mutation identification in the absence of normal tissue controls.
Kalatskaya I; Trinh QM; Spears M; McPherson JD; Bartlett JMS; Stein L
Genome Med; 2017 Jun; 9(1):59. PubMed ID: 28659176
[TBL] [Abstract][Full Text] [Related]
13. Rapid whole-genome mutational profiling using next-generation sequencing technologies.
Smith DR; Quinlan AR; Peckham HE; Makowsky K; Tao W; Woolf B; Shen L; Donahue WF; Tusneem N; Stromberg MP; Stewart DA; Zhang L; Ranade SS; Warner JB; Lee CC; Coleman BE; Zhang Z; McLaughlin SF; Malek JA; Sorenson JM; Blanchard AP; Chapman J; Hillman D; Chen F; Rokhsar DS; McKernan KJ; Jeffries TW; Marth GT; Richardson PM
Genome Res; 2008 Oct; 18(10):1638-42. PubMed ID: 18775913
[TBL] [Abstract][Full Text] [Related]
14. Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencing.
Patch AM; Nones K; Kazakoff SH; Newell F; Wood S; Leonard C; Holmes O; Xu Q; Addala V; Creaney J; Robinson BW; Fu S; Geng C; Li T; Zhang W; Liang X; Rao J; Wang J; Tian M; Zhao Y; Teng F; Gou H; Yang B; Jiang H; Mu F; Pearson JV; Waddell N
PLoS One; 2018; 13(1):e0190264. PubMed ID: 29320538
[TBL] [Abstract][Full Text] [Related]
15. A quantification method of somatic mutations in normal tissues and their accumulation in pediatric patients with chemotherapy.
Ueda S; Yamashita S; Nakajima M; Kumamoto T; Ogawa C; Liu YY; Yamada H; Kubo E; Hattori N; Takeshima H; Wakabayashi M; Iida N; Shiraishi Y; Noguchi M; Sato Y; Ushijima T
Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2123241119. PubMed ID: 35895679
[TBL] [Abstract][Full Text] [Related]
16. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of cancer genome sequencing.
Ku CS; Cooper DN; Roukos DH
World J Gastroenterol; 2013 Apr; 19(13):2011-8. PubMed ID: 23599619
[TBL] [Abstract][Full Text] [Related]
18. De novo structural mutation rates and gamete-of-origin biases revealed through genome sequencing of 2,396 families.
Belyeu JR; Brand H; Wang H; Zhao X; Pedersen BS; Feusier J; Gupta M; Nicholas TJ; Brown J; Baird L; Devlin B; Sanders SJ; Jorde LB; Talkowski ME; Quinlan AR
Am J Hum Genet; 2021 Apr; 108(4):597-607. PubMed ID: 33675682
[TBL] [Abstract][Full Text] [Related]
19. High-throughput sequencing in mutation detection: A new generation of genotoxicity tests?
Maslov AY; Quispe-Tintaya W; Gorbacheva T; White RR; Vijg J
Mutat Res; 2015 Jun; 776():136-43. PubMed ID: 25934519
[TBL] [Abstract][Full Text] [Related]
20. Genomic sequencing in cancer.
Tuna M; Amos CI
Cancer Lett; 2013 Nov; 340(2):161-70. PubMed ID: 23178448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
